Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Sun protection products

Do products containing titanium dioxide pose any health risks?

    • Congress Reports
    • Dermatology and venereology
    • Prevention and health care
    • RX
  • 2 minute read

Titanium dioxide acts as a UV filter and is present in numerous products, including cosmetics. It has been proven effective for preventing skin cancer and sunburns, but there have always been concerns about its safety. According to current studies, however, the risks are extremely low. 

In sunscreens, day creams, lotions and lip care products, titanium dioxide is only found in the form of nanoparticles [1]. These have a size of 1-10 nm and are suspected to penetrate dermal, respiratory and gastrointestinal barriers, spreading and thus posing a potential risk to the consumer. “In most human skin studies, nanotitanium dioxide particles generally remain on the skin surface after application of a sunscreen formulation. Only a small fraction of the nanoparticles penetrate deeper into the stratum corneum, but do not reach the viable cells of the epidermis or dermis,” said Laurence Imhof, MD, Head of the Department of Aesthetic Dermatology and Physical Therapies at the University Hospital Zurich, summarizing the results of a 2019 publication in JEADV [2].

Except for spray products, application is harmless  

Two animal studies suggested cutaneous penetration of titanium dioxide particles in nanoform into the stratum granulosum. In humans, there is only one corresponding finding from an in vivo case study, she said. Two subjects applied a commercial sunscreen containing nanotitanium dioxide particles six times daily [3]. Seven days after application, particles beyond the stratum corneum were detected in viable cells of the dermis using a transmission electron microscope. The speaker puts these findings into perspective: “That would mean that you would have to rub in these sunscreens very consistently several times a day, which is not the reality.” In the review by Dreno et al. the conclusion is as follows: Almost all studies conducted on humans or animals to date would have shown that the penetration of nanotitanium dioxide particles was largely limited to the stratum corneum. Except for the one study by Naess et al. the nanotitanium dioxide particles did not enter the skin beyond the surface layers to the viable cells. This was evident in both healthy and damaged skin. However, the authors advise against the use of spray products containing nanotiandioxide because inhaled nanoparticles can diffuse across the lung barrier and translocate to the rest of the body. While human data on this are sparse and inconsistent, he said, there are data from animal studies describing pneumonia. Regarding oral exposures of nanotitanium dioxide particles, for example during the application of lip care products, the authors mention that no adverse health effects are expected, although these particles could potentially penetrate the gastrointestinal mucosa after oral ingestion, but probably only to a limited extent.

Source: ZDFT 2020

 

Literature:

  1. Imhof L: What’s new in Aesthetic Dermatology? Laurence Imhof, MD, Zurich Dermatology Continuing Education Days (ZDFT), May 14-15, 2020.
  2. Dreno B, et al: Safety of titanium dioxide nanoparticles in cosmetics. JEADV 2019; 33 Suppl 7: 34-46.
  3. Naess EM, et al: Titanium dioxide nanoparticles in sunscreen penetrate the skin into viable layers of the epidermis: a clinical approach. Photodermatol Photoimmunol Photomed 2016; 32: 48-51.

 

DERMATOLOGIE PRAXIS 2020; 30(5): 22 (published 8/10/20, ahead of print).

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • DERMATOLOGIE PRAXIS
Related Topics
  • nanoparticles
  • Sunscreen
  • titanium dioxide
  • UV
Previous Article
  • Palliative care

When the end is near: support for patients in terminal situations

  • Education
  • General Internal Medicine
  • Geriatrics
  • Prevention and health care
  • RX
View Post
Next Article
  • Role of incretin-based therapy

GLP-1-RA and DPP-4 inhibitors in the management of type 2 diabetes.

  • Endocrinology and Diabetology
  • General Internal Medicine
  • Nephrology
  • Partner Content
  • RX
  • Studies
  • Training with partner
View Post
You May Also Like
View Post
  • 5 min
  • Multiple sclerosis

Avoiding the nocebo trap with natalizumab biosimilars

    • Education
    • Neurology
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 6 min
  • COPD and comorbidities

Exacerbation frequency is associated with cardiopulmonary disease burden

    • Education
    • General Internal Medicine
    • Pneumology
    • RX
    • Studies
View Post
  • 12 min
  • Multiple myeloma

DREAMM-8: Key study in the development of BCMA therapy up to DREAMM-14

    • Congress Reports
    • Hematology
    • Oncology
    • RX
    • Studies
View Post
  • 9 min
  • Catheter ablation for atrial fibrillation 2025

Pulsed field versus radio frequency – where do we stand?

    • Cardiology
    • Education
    • RX
    • Studies
    • Surgery
View Post
  • 8 min
  • Atopic dermatitis

From skin barrier disorder to atopic march?

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Infectiology
    • RX
    • Studies
View Post
  • 10 min
  • From the late residual valve to independent therapy

Tricuspid interventions 2025

    • Cardiology
    • Education
    • RX
    • Studies
    • Surgery
View Post
  • 5 min
  • Brain health

News from the Swiss Brain Health Plan (SBHP) 2023-2033

    • Education
    • Interviews
    • Neurology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
View Post
  • 3 min
  • Friedreich's ataxia

Treatment options have improved

    • Education
    • General Internal Medicine
    • Neurology
    • RX
    • Studies
Top Partner Content
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Consideration of the tumor microenvironment opens up new treatment options
  • 2
    What screening tools are helpful?
  • 3
    Scleroderma – Current recommendations for diagnosis and therapy 2025
  • 4
    Advantages of topical pharmacotherapy – Update 2025
  • 5
    Ritual, party or new therapy? Psychedelics and more: clinically illuminated

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.